1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 4,500 | 4,660 | 13:05 | |
| 4,500 | 4,700 | 21.08. |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| INSILICO MEDICINE Aktie jetzt für 0€ handeln | |||||
| Di | INSILICO (03696): VOLUNTARY ANNOUNCEMENT POSSIBLE PARTICIPATION IN THE ESTABLISHMENT OF AN INVESTMENT FUND | 3 | HKEx | ||
| Mo | INSILICO (03696): VOLUNTARY ANNOUNCEMENT INCLUSION IN MSCI GLOBAL SMALL CAP INDEXES | 2 | HKEx | ||
| 11.08. | INSILICO (03696): DATE OF BOARD MEETING | 2 | HKEx | ||
| 03.08. | INSILICO (03696): VOLUNTARY ANNOUNCEMENT INSILICO MEDICINE RECEIVES NMPA IND APPROVAL FOR ISM8969/HT-001, THE BLOOD-BRAIN-BARRIER-PENETRANT NLRP3 INHIBITOR ... | 2 | HKEx | ||
| 29.07. | Insilico Medicine Receives FDA Fast Track Designation for ISM6331, the AI-driven Pan-TEAD Inhibitor, in Advanced Mesothelioma | 378 | PR Newswire | FDA Fast Track Designation (FTD) aims to accelerate the review process of high-value assets, and ISM6331 marks Insilico's first FTD, recognizing the clinical potential... ► Artikel lesen | |
| 29.07. | INSILICO ISM6331 Granted FDA Fast Track Designation for Treatment of Advanced Mesothelioma | 1 | AASTOCKS | ||
| 29.07. | INSILICO (03696): VOLUNTARY ANNOUNCEMENT INSILICO MEDICINE RECEIVES FDA FAST TRACK DESIGNATION FOR ISM6331 IN ADVANCED MESOTHELIOMA | 2 | HKEx | ||
| 27.07. | GNQ Insilico Inc. - S-4, Registration of securities, business combinations | 2 | SEC Filings | ||
| 27.07. | Insilico Medicine to present phase 1 data for AI-designed drug | 3 | Investing.com | ||
| 27.07. | INSILICO to Release First-in-Human Phase I Clinical Data for Inhibitor ISM6331 | 1 | AASTOCKS | ||
| 27.07. | INSILICO (03696): VOLUNTARY ANNOUNCEMENT ISM6331 PHASE I CLINICAL DATA IN PATIENTS WITH MESOTHELIOMA AND ADVANCED SOLID TUMORS ACCEPTED FOR RAPID ORAL ... | 2 | HKEx | ||
| 24.07. | JPM Initiates INSILICO and XTALPI at Overweight | 4 | AASTOCKS | ||
| 23.07. | HSBC Research Initiates Coverage on INSILICO with Buy, TP at HKD84.5 | 10 | AASTOCKS | ||
| 15.07. | INSILICO (03696): LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION | 2 | HKEx | ||
| 15.07. | INSILICO (03696): RESIGNATION OF NON-EXECUTIVE DIRECTORS | 1 | HKEx | ||
| 15.07. | Bora, Insilico Launch Multi-Target AI Pharma Alliance | 1 | Contract Pharma | ||
| 15.07. | INSILICO (03696): VOLUNTARY ANNOUNCEMENT INSILICO MEDICINE AND BORA PHARMACEUTICALS ANNOUNCED A STRATEGIC ALLIANCE FOR AI-DRIVEN DRUG DISCOVERY AND DEVELOPMENT | 2 | HKEx | ||
| 15.07. | Insilico Medicine and Bora Pharmaceuticals Announce Strategic Alliance for AI-Driven Drug Discovery and Development | 482 | PR Newswire | Combines Insilico's Pharma.AI platform with Bora's global development, manufacturing, quality, and commercialization capabilities to explore a next-generation drug... ► Artikel lesen | |
| 13.07. | Insilico's Chinese partner returns for $177M pact to explore 'mass market' CNS indication | 1 | FierceBiotech | ||
| 13.07. | Deepening Collaboration in AI-Powered R&D Acceleration: Insilico Medicine and CMS announce additional collaborations in CNS diseases | 175 | PR Newswire | SHANGHAI, July 12, 2026 /PRNewswire/ -- Insilico Medicine ("Insilico", 03696.HK), a clinical-stage biotechnology company driven by generative artificial intelligence... ► Artikel lesen |
1 2 3 4 5 Weiter >>
97 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 46,600 | +0,83 % | EQS-News: Fresenius SE & Co. KGaA: Fresenius verkauft 7,8 Millionen Fresenius Medical Care-Aktien im Wert von rund 300 Millionen Euro | EQS-News: Fresenius SE & Co. KGaA
/ Schlagwort(e): Beteiligung/Unternehmensbeteiligung
Fresenius verkauft 7,8 Millionen Fresenius Medical Care-Aktien im Wert von rund 300 Millionen... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 40,140 | -1,83 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 40,200 | +0,98 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b), Abs. 3 der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung... ► Artikel lesen | |
| GERRESHEIMER | 27,600 | +1,40 % | Gerresheimer-Aktie: Nochmals Schwung holen für +30%? | Die Gerresheimer-Aktie verharrt seit Wochen in einer Konsolidierung unmittelbar unterhalb des entscheidenden Widerstands bei 29,56 €. In meiner vorherigen Analyse standen oberhalb von 30 € noch rund... ► Artikel lesen | |
| MEDTRONIC | 80,00 | +0,08 % | Medtronic: What Experts Really Say About Overactive Bladder | Breaking down the myths, realities, and innovations shaping pelvic healthcare today. NORTHAMPTON, MA / ACCESS Newswire / August 18, 2026 / Bladder leaks, frequent trips to the bathroom, and pelvic discomfort... ► Artikel lesen | |
| THERMO FISHER | 538,00 | -0,15 % | Thermo Fisher Scientific Stock: Analyst Estimates & Ratings | ||
| TELADOC HEALTH | 5,512 | +0,66 % | Teladoc Health, Inc.: Teladoc Health Appoints Financial Executive Mark Anquillare to Its Board of Directors | NEW YORK, Aug. 03, 2026 (GLOBE NEWSWIRE) -- Teladoc Health (NYSE: TDOC), the global leader in virtual care, today announced the appointment of Mark V. Anquillare to its board of directors. Mr. Anquillare... ► Artikel lesen | |
| ESSILORLUXOTTICA | 163,65 | -0,03 % | Milliardenmarkt Augengesundheit: Warum EssilorLuxottica und Carl Zeiss Meditec auf neue Technologien setzen - und wo Rise Nano Optics ins Spiel kommt | ||
| SERNOVA BIOTHERAPEUTICS | 0,069 | +1,46 % | Sernova Biotherapeutics, Inc.: Sernova Biotherapeutics Receives FDA Orphan Drug Designation for Autologous Islet Transplantation for Prevention of Diabetes Due to Total Pancreatectomy | TORONTO and BOSTON, June 17, 2026 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics Inc. ("Sernova" or the "Company") (TSX: SVA) (OTC: SEOVF) (FSE/XETRA: PSHO), a leading regenerative medicine company focused... ► Artikel lesen | |
| DEXCOM | 79,40 | +0,25 % | Biotech Stocks At 52-Week Highs - Eton Pharmaceuticals +44%, DXCM, ORKA, CON, ATAI | INDIANAPOLIS (dpa-AFX) - The following biotech stocks reached 52-week highs on August 14, 2026, following positive quarterly reports or an announced upcoming acquisition. Eton Pharmaceuticals... ► Artikel lesen | |
| SYNLAB | - | - | EQS-News: SYNLAB: Synnovis milestone: 2,000 revolutionary blood tests for NHS lung and breast cancer patients | EQS-News: SYNLAB
/ Key word(s): Miscellaneous
Synnovis milestone: 2,000 revolutionary blood tests for NHS lung and breast cancer patients
10.08.2026 / 09:00 CET/CEST
The... ► Artikel lesen | |
| OTTOBOCK | 59,70 | +1,53 % | GOLDMAN SACHS stuft Ottobock auf 'Buy' | NEW YORK (dpa-AFX Analyser) - Die US-Investmentbank Goldman Sachs hat das Kursziel für Ottobock von 93 auf 88 Euro gesenkt, aber die Einstufung auf "Buy" belassen. Richard Felton passte seine Schätzungen... ► Artikel lesen | |
| MCKESSON | 718,80 | -2,39 % | McKesson Corp. Reveals Fall In Q1 Bottom Line | WASHINGTON (dpa-AFX) - McKesson Corp. (MCK) reported earnings for first quarter that Drops, from last yearThe company's earnings totaled $614 million, or $5.17 per share. This compares with... ► Artikel lesen | |
| INMODE | 12,565 | -1,30 % | InMode Ltd.: InMode Reports Second Quarter 2026 Financial Results: Quarterly GAAP Revenues of $95.6 Million, Consistent with the Second Quarter of 2025 | YOKNEAM, Israel, Aug. 5, 2026 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) ("InMode"), a leading global provider of innovative medical technologies, today announced... ► Artikel lesen | |
| DAVITA | 149,30 | +0,30 % | Forever Committed to Excellence in Care: DaVita Community Care Report 2025 | NORTHAMPTON, MA / ACCESS Newswire / August 18, 2026 / Throughout DaVita's 25+ year history, we've led the way in patient-centered kidney care. Our work has played a key role in reducing hospitalizations... ► Artikel lesen |
Das Unternehmen INSILICO MEDICINE CAYMAN TOPCO kann der Branche Gesundheitswesen zugeordnet werden. Mit einer aktuellen Kursveränderung von +0,040 (+0,87 %) liegt der Kurs bei 4,640 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu INSILICO MEDICINE CAYMAN TOPCO finden Sie auf Wallstreet Online.